Loading organizations...
Key people at Octalfa.
Octalfa operates as a family-owned holding company creating and supporting innovative businesses, primarily in life sciences and chemistry. Its strategy includes seed financing for nascent ventures, co-founding new companies, and strategic acquisitions. The firm acts as a patient partner, providing expertise to guide its portfolio through development.
Established in 2007, Octalfa was co-founded by Gilles Alberici, Chairman, and Julien Alberici, CEO. Their founding insight emphasized combining capital with long-term, hands-on support, vital for nurturing groundbreaking enterprises. The family's direct involvement underscores commitment to fostering innovation and sustainable growth.
Octalfa supports aspiring entrepreneurs, early-stage companies, and management teams pursuing B2B acquisitions. Its vision is to be an active enabler, providing financial resources and strategic guidance. This aims to cultivate a resilient network of innovative companies, fostering their sustained growth and market impact.
Key people at Octalfa.
Octalfa has 3 tracked investments across 2 companies. The latest tracked deal is $4.2M Series A in Kimialys in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 23, 2025 | Kimialys | $4.2M Series A | Turenne Santé | Angels Sant, Badge, Evolem, Odiem Capital |
| Mar 17, 2015 | Amolyt Pharma | $1.9M Other Equity | — | Cema, CR E DIT Agricole CR Eation, RH E Alpes CR Eation, Sham Innovation Sant, Sofimac Partners, TAB Consulting |
| Sep 10, 2014 | Amolyt Pharma | $5.8M Other Equity | Olivier Martinez | Cema, Mounia Chaoui, TAB Consulting |